Wegovy® (semaglutide) label updated in Singapore with higher dose supported by STEP UP evidence
Up to one in three participants on semaglutide 7.2 mg achieved at least 25% weight loss over 72 weeks Mean weight loss with semaglutide 7.2 mg reached 21%, reflecting overall treatment efficacy Up to 84% of weight loss was driven by reductions in fat mass, supporting meaningful improvements in body...
dsm-firmenich awards 2026 Nutrition Research Grant to five projects investigating the role of nutrients and bio-actives in supporting healthy longevity in Asia Pacific
Record number of grant applications reflect growing interest in the emerging issue of healthy aging in Asia Pacific, where one in four people will be over 60 by 2050. SINGAPORE, July 8, 2026 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, today awarded the second round of the Nutrition Research Grant to five projects, each worth EUR50,000,...
OTR Therapeutics Enters Strategic Collaboration with LG Chem to Accelerate Development of Novel Oncology Therapies
SHANGHAI, July 8, 2026 /PRNewswire/ -- OTR Therapeutics, a clinical-stage biotechnology company dedicated to transforming early-stage innovations into globally impactful therapies, today announced that it has entered into a strategic collaboration agreement with LG Chem, a leading global company that specializes in life sciences as one of its core businesses. The strategic alliance is structured to accelerate joint efforts...
More Than 8,000 Entrepreneurs from 30 Countries Gather in Malaysia for QNET’s Global V-Convention 2026
Global Flagship convention reinforces responsible entrepreneurship, leadership development and innovation while unveiling new wellness, lifestyle and technology products PENANG, Malaysia, July 8, 2026 /PRNewswire/ -- Held under the theme "Reform. Perform. Transform.", V-Convention 2026 brought together more than 8,000 entrepreneurs and business leaders from 30 countries in Penang, Malaysia, reaffirming QNET's role as a global direct selling company...
Bambu Lab Announces 48-Hour Charity Fundraiser to Support Venezuela Earthquake Relief
AUSTIN, Texas, July 8, 2026 /PRNewswire/ -- Building on the ongoing relief efforts of Bambu Lab LATAM, including a USD 50,000 contribution toward earthquake recovery in Venezuela, Bambu Lab today announced a further step: a 48-hour community initiative beginning July 13 at 8:00 a.m. UTC−4, 2026. Use promo code 4Venezuela at checkout...
Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital peer-reviewed papers: the discovery-to-clinic journey in Nature Biotechnology, and positive Phase IIa clinical results in Nature Medicine Rentosertib represents a novel mechanism, novel AI-identified target, and novel AI-empowered molecule emerging from Insilico's aging-biology-driven Pharma.AI platform The GENESIS-IPF Phase IIa study showed manageable safety...
NYSE Content Update: Teradata AI Report Surveys 1,000 Global Tech + Data Leaders
NYSE issues a pre-market daily advisory direct from the trading floor. NEW YORK, July 7, 2026 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins. Annovis reveals latest feat...
Piramal Pharma’s FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones
MUMBAI, India, July 7, 2026 /PRNewswire/ -- Piramal Pharma Limited (PPL) (NSE: PPLPHARMA) (BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a year of strengthening its global platform, investing in differentiated capabilities, advancing sustainability, and delivering quality across operations. The report reflects Piramal...
Cambrex, Snapdragon Chemistry, and Q1 Scientific Recognized for Innovation and Sustainability in Pharma
EAST RUTHERFORD, N.J., July 7, 2026 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), proudly announces that Snapdragon Chemistry, a Cambrex company, together with NewAmsterdam Pharma, has received the American Chemical Society's 2026 Green Chemistry Challenge Award for the Greener Synthetic Pathway in the Synthesis of Pharmaceuticals. The...
HKSH’s First-in-Asia Comparative Study on Radiotherapy for Breast Cancer Reveals Hypofractionated Proton Therapy Prevents Breast Cancer Recurrence with 100% Survival Rate
Minimises Cardiopulmonary Concerns and Maintains Quality of Life HONG KONG, July 7, 2026 /PRNewswire/ -- The HKSH Cancer Centre under HKSH Medical Group (HKSH) introduced proton therapy in 2023, covering a wide range of cancer types including breast, prostate as well as head and neck cancers, and has since accumulated about 940 cases of clinical data. Around 45% of...
